Replication of an Association Between the Lymphoid Tyrosine Phosphatase Locus (LYP/PTPN22) With Type 1 Diabetes, and Evidence for Its Role as a General Autoimmunity Locus

Replication of an Association Between the Lymphoid Tyrosine Phosphatase Locus ( LYP/PTPN22 ) With Type 1 Diabetes, and Evidence for Its Role as a General Autoimmunity Locus Deborah Smyth 1 , Jason D. Cooper 1 , Joanne E. Collins 2 , Joanne M. Heward 2 , Jayne A. Franklyn 2 , Joanna M.M. Howson 1 , A...

Full description

Saved in:
Bibliographic Details
Published in:Diabetes (New York, N.Y.) Vol. 53; no. 11; pp. 3020 - 3023
Main Authors: SMYTH, Deborah, COOPER, Jason D, BARRATT, Bryan J, GUJA, Cristian, IONESCU-TIRGOVISTE, Constantin, SAVAGE, David A, DUNGER, David B, WIDMER, Barry, STRACHAN, David P, RING, Susan M, WALKER, Neil, CLAYTON, David G, COLLINS, Joanne E, TWELLS, Rebecca C. J, GOUGH, Stephen C. L, TODD, John A, HEWARD, Joanne M, FRANKLYN, Jayne A, HOWSON, Joanna M. M, VELLA, Adrian, NUTLAND, Sarah, RANCE, Helen E, MAIER, Lisa
Format: Journal Article
Language:English
Published: Alexandria, VA American Diabetes Association 01-11-2004
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Replication of an Association Between the Lymphoid Tyrosine Phosphatase Locus ( LYP/PTPN22 ) With Type 1 Diabetes, and Evidence for Its Role as a General Autoimmunity Locus Deborah Smyth 1 , Jason D. Cooper 1 , Joanne E. Collins 2 , Joanne M. Heward 2 , Jayne A. Franklyn 2 , Joanna M.M. Howson 1 , Adrian Vella 1 , Sarah Nutland 1 , Helen E. Rance 1 , Lisa Maier 1 , Bryan J. Barratt 3 , Cristian Guja 4 , Constantin Ionescu-Tı̂rgovişte 4 , David A. Savage 5 , David B. Dunger 6 , Barry Widmer 6 , David P. Strachan 7 , Susan M. Ring 8 , Neil Walker 1 , David G. Clayton 1 , Rebecca C.J. Twells 1 , Stephen C.L. Gough 2 and John A. Todd 1 1 Juvenile Diabetes Research Foundation (JDRF)/Wellcome Trust (WT) Diabetes and Inflammation Laboratory, Cambridge Institute for Medical Research (CIMR), University of Cambridge, Cambridge, U.K 2 Division of Medical Sciences, University of Birmingham, Birmingham, U.K 3 AstraZeneca, Macclesfield, U.K 4 Clinic of Diabetes, Institute of Diabetes, Nutrition and Metabolic Diseases “N. Paulescu,” Bucharest, Romania 5 Department of Medical Genetics, Queen’s University Belfast, Belfast City Hospital, Belfast, Northern Ireland 6 Department of Paediatrics, Addenbrooke’s Hospital, University of Cambridge, Cambridge, U.K 7 Department of Public Health Sciences, St. George’s Hospital Medical School, London, U.K 8 Avon Longitudinal Study of Parents and Children (ALSPAC), University of Bristol, Bristol, U.K Address correspondence and reprint requests to Professor John A. Todd, Juvenile Diabetes Research Foundation (JDRF)/Wellcome Trust (WT) Diabetes and Inflammation Laboratory, Cambridge Institute for Medical Research (CIMR), University of Cambridge, Cambridge, U.K. E-mail: john.todd{at}cimr.cam.ac.uk Abstract In the genetic analysis of common, multifactorial diseases, such as type 1 diabetes, true positive irrefutable linkage and association results have been rare to date. Recently, it has been reported that a single nucleotide polymorphism (SNP), 1858C>T, in the gene PTPN22 , encoding Arg620Trp in the lymphoid protein tyrosine phosphatase (LYP), which has been shown to be a negative regulator of T-cell activation, is associated with an increased risk of type 1 diabetes. Here, we have replicated these findings in 1,388 type 1 diabetic families and in a collection of 1,599 case and 1,718 control subjects, confirming the association of the PTPN22 locus with type 1 diabetes (family-based relative risk (RR) 1.67 [95% CI 1.46–1.91], and case-control odds ratio (OR) 1.78 [95% CI 1.54–2.06]; overall P = 6.02 × 10 −27 ). We also report evidence for an association of Trp 620 with another autoimmune disorder, Graves’ disease, in 1,734 case and control subjects ( P = 6.24 × 10 −4 ; OR 1.43 [95% CI 1.17–1.76]). Taken together, these results indicate a more general association of the PTPN22 locus with autoimmune disease. GRID, Genetic Resource Investigating Diabetes LYP, lymphoid protein tyrosine phosphatase SNP, single nucleotide polymorphism VNTR, variable number of tandem repeats Footnotes D.S. and J.D.C. contributed equally to this work. Accepted August 17, 2004. Received June 4, 2004. DIABETES
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
ISSN:0012-1797
1939-327X
DOI:10.2337/diabetes.53.11.3020